Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 2c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 2c, Revenues Beat

Akcea Reports Financial Results and Highlights for First Quarter 2019

May 8, 2019 4:07 PM EDT

Achieved First Quarter 2019 TEGSEDI® (inotersen) Global Net Product Revenues of $7 Million

 Novartis exercised its option to license AKCEA-APO(a)-LRx

Received marketing authorization for WAYLIVRA® (volanesorsen) in E.U.

Conference Call Webcast Wednesday, May 8, 4:30 p.m. ET... More